The defensive healthcare sector along with biotechnology stock-related exchange traded funds led the second quarter. During the last month of the quarter, Japan-related ETFs saw a resurgence.
The surge in markets this week helped the Dow Jones Industrial Average finish the quarter up 0.8%, although it lost 1.2% for June. The S&P 500 lost 0.4% for the quarter and 1.8% for the month. While the Nasdaq dropped 0.3%. and 2.2% respectively. The weaker-than-expected data on the U.S. economy and the financial concerns over the Eurozone kept the markets volatile through the quarter.
The top performing unleveraged ETF for the quarter was iShares Dow Jones U.S. Pharmaceutical Index Fund (NYSEArca: IHE), up 10.5%.
June’s ETF leaders were Korean and Japanese small-caps: IndexIQ South Korea Small Cap ETF (NYSEArca: SKOR), up 7.0%; WisdomTree Japan Small Cap Dividend (NYSEArca: DFJ), up 6.0% and SPDR Russell/Nomura Small Cap Japan ETF (NYSEArca: JSC), up 6.0%.
Click here for the full June ETF Performance Report. Or you can visit our ETF Analyzer at any time for current ETF performance.
Max Chen contributed to this article.
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.